The Natural History and the Staging of Chronic Hepatitis B: Time for Reevaluation of the Virus-Host Relationship Based on Molecular Virology and Immunopathogenesis Considerations?

Gastroenterology

Volumn 133, Issue 3, 2007, Pages 1031-1035

  Thompson, Alex ^a   Locarnini, Stephen ^a   Visvanathan, Kumar ^b  

^a VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; BETA INTERFERON; GAMMA INTERFERON; HEPATITIS B(E) ANTIGEN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANTIVIRAL THERAPY; EDITORIAL; GENOME; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; INNATE IMMUNITY; LIVER CELL; LIVER INJURY; MACROPHAGE; MUTATION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS LOAD;

EID: 34548512456     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.07.038     Document Type: Editorial

References (26)

1. Chisari F.V., and Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 13 (1995) 29-60
2. Lok A.S. Chronic hepatitis B. N Engl J Med 346 (2002) 1682-1683
3. Lok A.S., and Lai C.L. Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection. Incidence, predisposing factors and etiology. J Hepatol 10 (1990) 29-34
4. Chu C.M., Karayiannis P., Fowler M.J., et al. Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum. Hepatology 5 (1985) 431-434
5. Maini M.K., Boni C., Lee C.K., et al. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 191 (2000) 1269-1280
6. Visvanathan K., Skinner N.A., Thompson A.J., et al. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology 45 (2007) 102-110
7. Bowden S. Serological and molecular diagnosis. Semin Liver Dis 26 (2006) 97-103
8. Maruyama T., McLachlan A., Iino S., et al. The serology of chronic hepatitis B infection revisited. J Clin Invest 91 (1993) 2586-2595
9. Sung J.J., Wong M.L., Bowden S., et al. Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy. Gastroenterology 128 (2005) 1890-1897
10. Werle-Lapostolle B., Bowden S., Locarnini S., et al. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 126 (2004) 1750-1758
11. Hui C.K., Bowden S., Jackson K., et al. Clinical significance of intrahepatic hepatitis B virus covalently closed circular DNA in chronic hepatitis B patients who received cytotoxic chemotherapy. Blood 105 (2005) 2616-2617
12. Lok A.S. Navigating the maze of hepatitis B treatments. Gastroenterology 132 (2007) 1586-1594
13. Ghany M., and Liang T.J. Drug targets and molecular mechanisms of drug resistance in chronic hepatitis B. Gastroenterology 132 (2007) 1574-1585
14. Lim S.G., Cheng Y., Guindon S., et al. Viral quasi-species evolution during Hepatitis Be antigen seroconversion. Gastroenterology 133 (2007) 951-958
15. Volz T., Lutgehetmann M., Wachtler P., et al. Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients. Gastroenterology 133 (2007) 843-852
16. Wursthorn K., Lutgehetmann M., Dandri M., et al. Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B. Hepatology 44 (2006) 675-684
17. Bozkaya H., Akarca U.S., Ayola B., et al. High degree of conservation in the hepatitis B virus core gene during the immune tolerant phase in perinatally acquired chronic hepatitis B virus infection. J Hepatol 26 (1997) 508-516
18. Bozkaya H., Ayola B., and Lok A.S. High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection. Hepatology 24 (1996) 32-37
19. Hannoun C., Horal P., and Lindh M. Long-term mutation rates in the hepatitis B virus genome. J Gen Virol 81 (2000) 75-83
20. Laras A., Koskinas J., Dimou E., et al. Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients. Hepatology 44 (2006) 694-702
21. Wong D.K., Yuen M.F., Yuan H., et al. Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients. Hepatology 40 (2004) 727-737
22. Tacke F., Gehrke C., Luedde T., et al. Basal core promoter and precore mutations in the hepatitis B virus genome enhance replication efficacy of Lamivudine-resistant mutants. J Virol 78 (2004) 8524-8535
23. Wieland S.F., and Chisari F.V. Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol 79 (2005) 9369-9380
24. Heise T., Guidotti L.G., Cavanaugh V.J., et al. Hepatitis B virus RNA-binding proteins associated with cytokine-induced clearance of viral RNA from the liver of transgenic mice. J Virol 73 (1999) 474-481
25. Heise T., Guidotti L.G., and Chisari F.V. La autoantigen specifically recognizes a predicted stem-loop in hepatitis B virus RNA. J Virol 73 (1999) 5767-5776
26. Heise T., Guidotti L.G., and Chisari F.V. Characterization of nuclear RNases that cleave hepatitis B virus RNA near the La protein binding site. J Virol 75 (2001) 6874-6883